PRECIOUS SEA
Natural health product licensed in Canada
- Licence holder
- Eastern Currents Ltd.
- NPN or DIN-HM
- 80046963
- Status
- Inactive licence
- Licence date
- 9 December 2013
- Revision date
- 7 July 2014
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Cyperus rotundus L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes et allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Atractylodes macrocephala Source : Rhizome Extraction ratio : 7.5:1 Dry plant equivalent : 225 mg | 30 mg | Not calculated |
| Leonurus japonicus Source : Sommité Extraction ratio : 7.5:1 Dry plant equivalent : 168.75 mg | 22.5 mg | Not calculated |
| Polygonatum sibiricum Source : Rhizome Extraction ratio : 7.5:1 Dry plant equivalent : 225 mg | 30 mg | Not calculated |
| Panax ginseng Source : Racine Extraction ratio : 7.5:1 Dry plant equivalent : 225 mg | 30 mg | Not calculated |
| Cyperus rotundus Source : Rhizome Extraction ratio : 7.5:1 Dry plant equivalent : 168.75 mg | 22.5 mg | Not calculated |
| Codonopsis pilosula Source : Racine Extraction ratio : 7.5:1 Dry plant equivalent : 225 mg | 30 mg | Not calculated |
| Reynoutria multiflora Source : Racine Extraction ratio : 7.5:1 Dry plant equivalent : 262.5 mg | 35 mg | Not calculated |
Non-medicinal ingredients
Cellulose, Fécule de pomme de terre
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Comprimé | 3 days |
Uses authorised in Canada
Product manufactured based on Traditional Chinese Medicine theory.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For health care practitioner dispensing only. Consult a health care practitioner for prolonged use; if symptoms persist or worsen, or if new symptoms develop; and prior to use if you have serious or major conditions or if taking prescription medications.
Source
Official Health Canada record, licence 80046963
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging